SCHEMBL19935895

SCHEMBL19935895

CC1C=C(B2OC(C)(C)C(C)(C)O2)C[C@@H](C)N1C(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 2/20 0.38
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
ABCB1 P08183 1/20 0.32
AAK1 Q2M2I8 1/20 0.32
PREP P48147 1/20 0.32
P2RX7 Q99572 1/20 0.31
KDM1A O60341 1/20 0.31
HSD11B1 P28845 1/20 0.31
BUB1 O43683 1/20 0.31
EED O75530 1/20 0.31
RBBP4 Q09028 1/20 0.31
SUZ12 Q15022 1/20 0.31
EZH2 Q15910 1/20 0.31
USP2 O75604 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
MAPK1 P28482 2/20 0.30
BACE1 P56817 1/20 0.30
BACE2 Q9Y5Z0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182988 1.00 USP30 (0.38) USP30CHRM2CHRM1CHRM3ABCB1
SCHEMBL19935894 1.00 USP30 (0.38) USP30CHRM2CHRM1CHRM3ABCB1
SCHEMBL4887916 1.00 USP30 (0.38) USP30CHRM2CHRM1CHRM3ABCB1
SCHEMBL25172608 0.82 P2RX7 (0.35) P2RX7MAPK1
SCHEMBL28381934 0.82 P2RX7 (0.35) P2RX7MAPK1
SCHEMBL12543898 0.82 P2RX7 (0.35) P2RX7MAPK1
SCHEMBL19078451 0.82 USP30 (0.38) USP30AAK1P2RX7BUB1USP2
SCHEMBL12461395 0.80 USP30 (0.39) USP30P2RX7HSD11B1USP2SMN1; SMN2
SCHEMBL21340355 0.80 USP30 (0.39) USP30P2RX7HSD11B1USP2SMN1; SMN2
SCHEMBL16272001 0.80 USP30 (0.39) USP30P2RX7HSD11B1USP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018044767-A2 AMINOPYRIMIDINES AS ALK INHIBITORS THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2018-03-08 WO disclosed